Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Dexamethasone suppresses the proliferation and migration of VSMCs by FAK in high glucose conditions

Fig. 4

Relative protein values of FAK in vascular smooth muscle cells (VSMCs) treated with dexamethasone. Gel image A 24-h period B (control high glucose vs. dexamethasone (10–7 M + HG) p = 0.745; control high glucose vs. dexamethasone (10–6 M + HG) P = 0.307; control high glucose vs. dexamethasone (10–5 M + HG) p < 0.0001). 48-h period C (control high glucose vs. dexamethasone (10–7 M + HG) p = 0.430; control high glucose vs. dexamethasone (10–6 M + HG) P < 0.0001; control high glucose vs. dexamethasone (10–5 M + HG) p < 0.0001). The cellular experiments are repeated three times (n = 3). Data are presented in mean and standard deviation (mean ± SD). *** p < 0.001, **** p < 0.0001. (N (Normal); HG (High Glucose))

Back to article page